IL10 and myeloid sarcoma: In stable MS patients, higher levels of PDL1 and IL10 were observed in monocytes and B cells after MBP stimulation compared with active MS patients (46) and downregulation of immunosuppressive molecules PD-1 and PDL1 was observed in MS patients compared with healthy individuals (47).